chr3-128912587-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The ENST00000308982.12(ACAD9):c.1846C>T(p.Pro616Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000308982.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACAD9 | NM_014049.5 | c.1846C>T | p.Pro616Ser | missense_variant | 18/18 | ENST00000308982.12 | NP_054768.2 | |
CFAP92 | NM_001394090.1 | c.3281-2254G>A | intron_variant | ENST00000645291.3 | NP_001381019.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACAD9 | ENST00000308982.12 | c.1846C>T | p.Pro616Ser | missense_variant | 18/18 | 1 | NM_014049.5 | ENSP00000312618 | P1 | |
CFAP92 | ENST00000645291.3 | c.3281-2254G>A | intron_variant | NM_001394090.1 | ENSP00000496592 | P2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251486Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135920
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727232
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Acyl-CoA dehydrogenase 9 deficiency Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 06, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 26, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 19, 2023 | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACAD9 protein function. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 242523). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 616 of the ACAD9 protein (p.Pro616Ser). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of mitochondrial complex I deficiency (PMID: 25326637, 30831263). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.1846C>T (p.P616S) alteration is located in exon 18 (coding exon 18) of the ACAD9 gene. This alteration results from a C to T substitution at nucleotide position 1846, causing the proline (P) at amino acid position 616 to be replaced by a serine (S). Based on data from gnomAD, the T allele has an overall frequency of <0.001% (1/251486) total alleles studied. The highest observed frequency was 0.003% (1/34592) of Latino alleles. This variant was identified in one individual with cardiomyopathy, lactic acidosis, complex I deficiency on muscle biopsy, and a second ACAD9 variant in trans (Nogueira, 2019). It was also in trans with a second ACAD9 variant in an individual with lactic acidosis, metabolic acidosis, encephalopathy, developmental delay, and emesis (Lee, 2014). This amino acid position is highly conserved in available vertebrate species. The in silico prediction for this alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at